7024.44南非幣50.44(0.71%)
2023/05/31更新
績效 / 1月0.21%
3月3.06%
1年21.42%
晨星評等-
- 1.現金0.94%
- 2.股票12.63%
- 3.債券0.13%
- 4.其他86.30%
- 1.美國86.64%
- 2.歐洲不包含歐元區6.26%
- 3.加拿大4.83%
- 4.新興亞洲1.09%
- 5.英國0.37%
- 1.Biogen Inc5.89%
- 2.Vertex Pharmaceuticals Inc5.73%
- 3.argenx SE ADR4.86%
- 4.Biomarin Pharmaceutical Inc4.60%
- 5.Regeneron Pharmaceuticals Inc4.34%
- 6.Intra-Cellular Therapies Inc3.17%
- 7.Xenon Pharmaceuticals Inc3.03%
- 8.Incyte Corp3.02%
- 9.Seagen Inc Ordinary Shares2.95%
- 10.Genmab A/S2.93%
- 1.現金0.94%
- 2.股票12.63%
- 3.債券0.13%
- 4.其他86.30%
- 1.美國86.64%
- 2.歐洲不包含歐元區6.26%
- 3.加拿大4.83%
- 4.新興亞洲1.09%
- 5.英國0.37%
- 1.Biogen Inc5.89%
- 2.Vertex Pharmaceuticals Inc5.73%
- 3.argenx SE ADR4.86%
- 4.Biomarin Pharmaceutical Inc4.60%
- 5.Regeneron Pharmaceuticals Inc4.34%
- 6.Intra-Cellular Therapies Inc3.17%
- 7.Xenon Pharmaceuticals Inc3.03%
- 8.Incyte Corp3.02%
- 9.Seagen Inc Ordinary Shares2.95%
- 10.Genmab A/S2.93%